Polyvalent integrin antagonist-decorated superparamagnetic iron oxide nanoparticles for triggering apoptosis in human leukemia cancer cells
JOURNAL OF NANOPARTICLE RESEARCH, vol.15, no.1, 2013 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 15 Issue: 1
- Publication Date: 2013
- Doi Number: 10.1007/s11051-012-1350-2
- Journal Name: JOURNAL OF NANOPARTICLE RESEARCH
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Keywords: MAASP monomers, RGD mimic, Poly(MAASP-co-EDMA) shell, Super paramagnetic iron oxide nanoparticles (SPIONs), RGD, ADHESION, ANGIOGENESIS, RECOGNITION, PARTICLES, CARCINOMA, MIGRATION, THERAPY
- Anadolu University Affiliated: Yes
Abstract
Integrin family members are the main mediators of cell adhesion to the extracellular matrix and active as intra- and extracellular signaling molecules in a variety of processes. They bind to their ligands by interacting with short amino acid sequences, that is, RGD (arginine-glycine-aspartic acid) sequence. RGD sequences have been used to enhance cell binding to artificial surfaces, so RGD mimics have been used to block integrin binding to its ligand. Integrin-ligand interactions are dependent on divalent cations, and Mg2+ provide higher-affinity binding to ligand for many integrins. In this study, we have designed new integrin antagonists using methacryloyl amidoaspartic acid (MAASP) monomer-conjugated silanized super paramagnetic iron oxide nanoparticles (SPIONs, the size of the nanoparticles was verified with an average size of 32.6 nm) and poly(MAASP-co-EDMA) shell-decorated silanized SPIONs. Several mechanisms have been proposed to describe uptake of modified SPIONs into the cells, including receptor-mediated endocytosis. Our aim is to bind these modified SPIONs to the integrin-mediated aspartic acid ends of MAASP monomers and block integrin binding to their ligand.